Table 1.
Comparison of clinical parameters and antibody titers between HCW vaccinated with BNT162b2 or mRNA-1273.
| BNT162b2 | mRNA-1273 | p-value* | |
|---|---|---|---|
| No of subjects | 722 | 43 | |
| Age, median (IQR) | 46 (35–55) | 48 (37–54) | 0.671 |
| Sex | |||
| Female, n (%) | 526 (72.9) | 30 (69.8) | 0.659 |
| Male, n (%) | 196 (27.1) | 13 (30.2) | |
| Anti-S IgG titers measured at 1 month after vaccination in absence of COVID-19, median (IQR) | 532.55 (310.85–804.55) AU/mL | 736.95 (484.8–988) AU/mL | 0.016 |
| Anti-S IgG titers measured at 1 month after vaccination in case of prior COVID-19, median (IQR) | 1072.65 (503.1–1606.7) AU/mL | 1813.4 (865.4–2500) AU/mL | 0.019 |
IQR: interquartile range; Anti-S, anti-Spike RBD.
*
Mann-Whitney test for age and anti-S IgG titers, Chi-squared test for sex.